Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Noriko Kimura, Katsuya Suzuki, Tsutomu Takeuchi

ABSTRACT

Background: Tumor necrosis factor inhibitor therapy for rheumatoid arthritis (RA) patients reduces disease activity, but little is known about the factors that correlate with continuation of remission. To identify demographics and clinical characteristics associated with achievement and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab (ADA). Methods: In this retrospective cohort study, clinical outcome was retrospectively evaluated in RA patients that received ADA at a single institution using 28-joint disease activity score with erythrocyte sedimentation rate (DAS28-ESR). Sustained remission was defined as DAS28-ESR < 2.6 for more than 6 months, and continuation of sustained remission was defined as DAS28-ESR < 2.6 that was maintained until the end of the observation period. Results: Of 122 patients undergoing treatment with ADA between July 2008 and April 2014, 39 (32.0%) achieved sustained remission, and 22 of the 39 (56.4%) continued sustained remission until the end of the observation period (median, 20.5 months). Four of the 39 patients discontinued ADA because of remission, but 3 of these 4 patients restarted ADA because of RA flare. DAS28-ESR at the time of achievement of remission was lower in the subgroup of patients with continuation of sustained remission than the subgroup with RA flare. Conclusion: Of 122 patients, 39 (32.0%) achieved remission that was sustained for more than 6 months and 22 of the 39 patients (56.4%) continued sustained remission until the end of the observation period. Continuation of sustained remission was correlated with DAS28-ESR at the time of achievement of remission. More... »

PAGES

5

References to SciGraph publications

Journal

TITLE

Inflammation and Regeneration

ISSUE

1

VOLUME

39

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s41232-019-0094-0

DOI

http://dx.doi.org/10.1186/s41232-019-0094-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112985288

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30956738


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Keio University", 
          "id": "https://www.grid.ac/institutes/grid.26091.3c", 
          "name": [
            "Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, 160-8582, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Noriko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Keio University", 
          "id": "https://www.grid.ac/institutes/grid.26091.3c", 
          "name": [
            "Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, 160-8582, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Katsuya", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Keio University", 
          "id": "https://www.grid.ac/institutes/grid.26091.3c", 
          "name": [
            "Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, 160-8582, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeuchi", 
        "givenName": "Tsutomu", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/rmdopen-2015-000133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000919219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/rmdopen-2015-000133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000919219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61751-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010989086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61751-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010989086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2012-202433", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018815513"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/rmdopen-2015-000189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019804925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/rmdopen-2015-000189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019804925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780310302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021989941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-204016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028126484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780230202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038964975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/s10165-011-0516-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039736994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrrheum.2010.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041079966", 
          "https://doi.org/10.1038/nrrheum.2010.154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrrheum.2010.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041079966", 
          "https://doi.org/10.1038/nrrheum.2010.154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780380107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048589850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21519", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049214196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21519", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049214196"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "Background: Tumor necrosis factor inhibitor therapy for rheumatoid arthritis (RA) patients reduces disease activity, but little is known about the factors that correlate with continuation of remission. To identify demographics and clinical characteristics associated with achievement and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab (ADA).\nMethods: In this retrospective cohort study, clinical outcome was retrospectively evaluated in RA patients that received ADA at a single institution using 28-joint disease activity score with erythrocyte sedimentation rate (DAS28-ESR). Sustained remission was defined as DAS28-ESR <\u20092.6 for more than 6\u00a0months, and continuation of sustained remission was defined as DAS28-ESR <\u20092.6 that was maintained until the end of the observation period.\nResults: Of 122 patients undergoing treatment with ADA between July 2008 and April 2014, 39 (32.0%) achieved sustained remission, and 22 of the 39 (56.4%) continued sustained remission until the end of the observation period (median, 20.5\u00a0months). Four of the 39 patients discontinued ADA because of remission, but 3 of these 4 patients restarted ADA because of RA flare. DAS28-ESR at the time of achievement of remission was lower in the subgroup of patients with continuation of sustained remission than the subgroup with RA flare.\nConclusion: Of 122 patients, 39 (32.0%) achieved remission that was sustained for more than 6\u00a0months and 22 of the 39 patients (56.4%) continued sustained remission until the end of the observation period. Continuation of sustained remission was correlated with DAS28-ESR at the time of achievement of remission.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s41232-019-0094-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1040309", 
        "issn": [
          "1880-9693", 
          "1880-8190"
        ], 
        "name": "Inflammation and Regeneration", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "name": "Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab", 
    "pagination": "5", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s41232-019-0094-0"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "565e8f94b0a5c31e34c30cb3567a291b030535bc301aa418625381dd6b238f39"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112985288"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101479577"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30956738"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s41232-019-0094-0", 
      "https://app.dimensions.ai/details/publication/pub.1112985288"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91456_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs41232-019-0094-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s41232-019-0094-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s41232-019-0094-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s41232-019-0094-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s41232-019-0094-0'


 

This table displays all metadata directly associated to this object as RDF triples.

114 TRIPLES      21 PREDICATES      40 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s41232-019-0094-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nc02844439dce4c9f8495d0909e298599
4 schema:citation sg:pub.10.1038/nrrheum.2010.154
5 https://doi.org/10.1002/art.1780230202
6 https://doi.org/10.1002/art.1780310302
7 https://doi.org/10.1002/art.1780380107
8 https://doi.org/10.1002/art.21519
9 https://doi.org/10.1016/s0140-6736(13)61751-1
10 https://doi.org/10.1136/annrheumdis-2012-202433
11 https://doi.org/10.1136/annrheumdis-2013-204016
12 https://doi.org/10.1136/rmdopen-2015-000133
13 https://doi.org/10.1136/rmdopen-2015-000189
14 https://doi.org/10.3109/s10165-011-0516-6
15 schema:datePublished 2019-12
16 schema:datePublishedReg 2019-12-01
17 schema:description Background: Tumor necrosis factor inhibitor therapy for rheumatoid arthritis (RA) patients reduces disease activity, but little is known about the factors that correlate with continuation of remission. To identify demographics and clinical characteristics associated with achievement and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab (ADA). Methods: In this retrospective cohort study, clinical outcome was retrospectively evaluated in RA patients that received ADA at a single institution using 28-joint disease activity score with erythrocyte sedimentation rate (DAS28-ESR). Sustained remission was defined as DAS28-ESR < 2.6 for more than 6 months, and continuation of sustained remission was defined as DAS28-ESR < 2.6 that was maintained until the end of the observation period. Results: Of 122 patients undergoing treatment with ADA between July 2008 and April 2014, 39 (32.0%) achieved sustained remission, and 22 of the 39 (56.4%) continued sustained remission until the end of the observation period (median, 20.5 months). Four of the 39 patients discontinued ADA because of remission, but 3 of these 4 patients restarted ADA because of RA flare. DAS28-ESR at the time of achievement of remission was lower in the subgroup of patients with continuation of sustained remission than the subgroup with RA flare. Conclusion: Of 122 patients, 39 (32.0%) achieved remission that was sustained for more than 6 months and 22 of the 39 patients (56.4%) continued sustained remission until the end of the observation period. Continuation of sustained remission was correlated with DAS28-ESR at the time of achievement of remission.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree true
21 schema:isPartOf N4e4de5f307674903b3144c3caca1e4a6
22 Ne643edff57614159bdd6b17b84d9b7b5
23 sg:journal.1040309
24 schema:name Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
25 schema:pagination 5
26 schema:productId N3ccf3f389e8a40858d453fd8f4708ab5
27 N40de2dcfe2b9447f85416859c4e7853a
28 N5f3fbd3320b44c038694b00b8acc0a70
29 Nc4dc7f92d8e3496dbfa01a7664995c74
30 Nebdee0bb07ca4f11b92dc3918296fd71
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112985288
32 https://doi.org/10.1186/s41232-019-0094-0
33 schema:sdDatePublished 2019-04-15T09:02
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher Ne7a205cc565a4fe68b3dbd4ceb6df911
36 schema:url https://link.springer.com/10.1186%2Fs41232-019-0094-0
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N3004dcc43ebe406ab456fbca89e1df15 schema:affiliation https://www.grid.ac/institutes/grid.26091.3c
41 schema:familyName Takeuchi
42 schema:givenName Tsutomu
43 rdf:type schema:Person
44 N3869fa2e0ee04c949e7630927cb751f9 rdf:first N3004dcc43ebe406ab456fbca89e1df15
45 rdf:rest rdf:nil
46 N3ccf3f389e8a40858d453fd8f4708ab5 schema:name readcube_id
47 schema:value 565e8f94b0a5c31e34c30cb3567a291b030535bc301aa418625381dd6b238f39
48 rdf:type schema:PropertyValue
49 N40de2dcfe2b9447f85416859c4e7853a schema:name pubmed_id
50 schema:value 30956738
51 rdf:type schema:PropertyValue
52 N4e4de5f307674903b3144c3caca1e4a6 schema:volumeNumber 39
53 rdf:type schema:PublicationVolume
54 N5f3fbd3320b44c038694b00b8acc0a70 schema:name nlm_unique_id
55 schema:value 101479577
56 rdf:type schema:PropertyValue
57 N8058ebb9c72f4b5089cfc4c41e9aa9a7 rdf:first Nfb943edb18d14c0e97261302328f3262
58 rdf:rest N3869fa2e0ee04c949e7630927cb751f9
59 Nc02844439dce4c9f8495d0909e298599 rdf:first Nf885e27bf2694f5583e258eedc56908d
60 rdf:rest N8058ebb9c72f4b5089cfc4c41e9aa9a7
61 Nc4dc7f92d8e3496dbfa01a7664995c74 schema:name doi
62 schema:value 10.1186/s41232-019-0094-0
63 rdf:type schema:PropertyValue
64 Ne643edff57614159bdd6b17b84d9b7b5 schema:issueNumber 1
65 rdf:type schema:PublicationIssue
66 Ne7a205cc565a4fe68b3dbd4ceb6df911 schema:name Springer Nature - SN SciGraph project
67 rdf:type schema:Organization
68 Nebdee0bb07ca4f11b92dc3918296fd71 schema:name dimensions_id
69 schema:value pub.1112985288
70 rdf:type schema:PropertyValue
71 Nf885e27bf2694f5583e258eedc56908d schema:affiliation https://www.grid.ac/institutes/grid.26091.3c
72 schema:familyName Kimura
73 schema:givenName Noriko
74 rdf:type schema:Person
75 Nfb943edb18d14c0e97261302328f3262 schema:affiliation https://www.grid.ac/institutes/grid.26091.3c
76 schema:familyName Suzuki
77 schema:givenName Katsuya
78 rdf:type schema:Person
79 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
80 schema:name Medical and Health Sciences
81 rdf:type schema:DefinedTerm
82 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
83 schema:name Clinical Sciences
84 rdf:type schema:DefinedTerm
85 sg:journal.1040309 schema:issn 1880-8190
86 1880-9693
87 schema:name Inflammation and Regeneration
88 rdf:type schema:Periodical
89 sg:pub.10.1038/nrrheum.2010.154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041079966
90 https://doi.org/10.1038/nrrheum.2010.154
91 rdf:type schema:CreativeWork
92 https://doi.org/10.1002/art.1780230202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038964975
93 rdf:type schema:CreativeWork
94 https://doi.org/10.1002/art.1780310302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021989941
95 rdf:type schema:CreativeWork
96 https://doi.org/10.1002/art.1780380107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048589850
97 rdf:type schema:CreativeWork
98 https://doi.org/10.1002/art.21519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049214196
99 rdf:type schema:CreativeWork
100 https://doi.org/10.1016/s0140-6736(13)61751-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010989086
101 rdf:type schema:CreativeWork
102 https://doi.org/10.1136/annrheumdis-2012-202433 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018815513
103 rdf:type schema:CreativeWork
104 https://doi.org/10.1136/annrheumdis-2013-204016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028126484
105 rdf:type schema:CreativeWork
106 https://doi.org/10.1136/rmdopen-2015-000133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000919219
107 rdf:type schema:CreativeWork
108 https://doi.org/10.1136/rmdopen-2015-000189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019804925
109 rdf:type schema:CreativeWork
110 https://doi.org/10.3109/s10165-011-0516-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039736994
111 rdf:type schema:CreativeWork
112 https://www.grid.ac/institutes/grid.26091.3c schema:alternateName Keio University
113 schema:name Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, 160-8582, Tokyo, Japan
114 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...